458 related articles for article (PubMed ID: 24027197)
1. A hormone-DNA repair circuit governs the response to genotoxic insult.
Goodwin JF; Schiewer MJ; Dean JL; Schrecengost RS; de Leeuw R; Han S; Ma T; Den RB; Dicker AP; Feng FY; Knudsen KE
Cancer Discov; 2013 Nov; 3(11):1254-71. PubMed ID: 24027197
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor signaling regulates DNA repair in prostate cancers.
Polkinghorn WR; Parker JS; Lee MX; Kass EM; Spratt DE; Iaquinta PJ; Arora VK; Yen WF; Cai L; Zheng D; Carver BS; Chen Y; Watson PA; Shah NP; Fujisawa S; Goglia AG; Gopalan A; Hieronymus H; Wongvipat J; Scardino PT; Zelefsky MJ; Jasin M; Chaudhuri J; Powell SN; Sawyers CL
Cancer Discov; 2013 Nov; 3(11):1245-53. PubMed ID: 24027196
[TBL] [Abstract][Full Text] [Related]
3. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.
Goodwin JF; Kothari V; Drake JM; Zhao S; Dylgjeri E; Dean JL; Schiewer MJ; McNair C; Jones JK; Aytes A; Magee MS; Snook AE; Zhu Z; Den RB; Birbe RC; Gomella LG; Graham NA; Vashisht AA; Wohlschlegel JA; Graeber TG; Karnes RJ; Takhar M; Davicioni E; Tomlins SA; Abate-Shen C; Sharifi N; Witte ON; Feng FY; Knudsen KE
Cancer Cell; 2015 Jul; 28(1):97-113. PubMed ID: 26175416
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
Dondoo TO; Fukumori T; Daizumoto K; Fukawa T; Kohzuki M; Kowada M; Kusuhara Y; Mori H; Nakatsuji H; Takahashi M; Kanayama HO
Anticancer Res; 2017 Jan; 37(1):125-134. PubMed ID: 28011482
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor signaling fuels DNA repair and radioresistance in prostate cancer.
Bartek J; Mistrik M; Bartkova J
Cancer Discov; 2013 Nov; 3(11):1222-4. PubMed ID: 24203954
[TBL] [Abstract][Full Text] [Related]
6. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.
Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E
J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660
[TBL] [Abstract][Full Text] [Related]
7. Dual roles of PARP-1 promote cancer growth and progression.
Schiewer MJ; Goodwin JF; Han S; Brenner JC; Augello MA; Dean JL; Liu F; Planck JL; Ravindranathan P; Chinnaiyan AM; McCue P; Gomella LG; Raj GV; Dicker AP; Brody JR; Pascal JM; Centenera MM; Butler LM; Tilley WD; Feng FY; Knudsen KE
Cancer Discov; 2012 Dec; 2(12):1134-49. PubMed ID: 22993403
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Dylgjeri E; McNair C; Goodwin JF; Raymon HK; McCue PA; Shafi AA; Leiby BE; de Leeuw R; Kothari V; McCann JJ; Mandigo AC; Chand SN; Schiewer MJ; Brand LJ; Vasilevskaya I; Gordon N; Laufer TS; Gomella LG; Lallas CD; Trabulsi EJ; Feng FY; Filvaroff EH; Hege K; Rathkopf D; Knudsen KE
Clin Cancer Res; 2019 Sep; 25(18):5623-5637. PubMed ID: 31266833
[TBL] [Abstract][Full Text] [Related]
9. The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics.
Comstock CE; Knudsen KE
Cell Cycle; 2007 Jun; 6(11):1307-13. PubMed ID: 17568191
[TBL] [Abstract][Full Text] [Related]
10. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
Zhang Y; Won SH; Jiang C; Lee HJ; Jeong SJ; Lee EO; Zhang J; Ye M; Kim SH; Lü J
Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
[TBL] [Abstract][Full Text] [Related]
11. Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.
Yin Y; Li R; Xu K; Ding S; Li J; Baek G; Ramanand SG; Ding S; Liu Z; Gao Y; Kanchwala MS; Li X; Hutchinson R; Liu X; Woldu SL; Xing C; Desai NB; Feng FY; Burma S; de Bono JS; Dehm SM; Mani RS; Chen BPC; Raj GV
Cancer Res; 2017 Sep; 77(18):4745-4754. PubMed ID: 28754673
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: understanding why.
McCarthy N
Nat Rev Cancer; 2013 Nov; 13(11):754. PubMed ID: 24108098
[No Abstract] [Full Text] [Related]
13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
16. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
17. Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.
Wang Y; Xu H; Liu T; Huang M; Butter PP; Li C; Zhang L; Kao GD; Gong Y; Maity A; Koumenis C; Fan Y
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415883
[TBL] [Abstract][Full Text] [Related]
18. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Xu L; Yin Y; Li Y; Chen X; Chang Y; Zhang H; Liu J; Beasley J; McCaw P; Zhang H; Young S; Groth J; Wang Q; Locasale JW; Gao X; Tang DG; Dong X; He Y; George D; Hu H; Huang J
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753479
[TBL] [Abstract][Full Text] [Related]
19. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C
EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer.
Zhang Y; Castaneda S; Dumble M; Wang M; Mileski M; Qu Z; Kim S; Shi V; Kraft P; Gao Y; Pak J; Sapra P; Bandaru R; Zhao H; Vessella RL; Horak ID; Greenberger LM
Mol Cancer Ther; 2011 Dec; 10(12):2309-19. PubMed ID: 22027692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
